Elevance Health Inc. (ELV) Stock

NYSE
HealthcareHealthcare Plans Website

ELV has an Alpha Score of 37 out of 100 (weak), computed on Nov 20, 2026 from 3 of 4 sub-scores. 14 members of Congress disclosed 35 trades in ELV since 2022: 21 purchases and 14 sales, most recently Alan Armstrong (purchase, Mar 27, 2026). 8 of the hedge funds AlphaScala tracks reported ELV in 13F filings for the quarter ended Sep 30, 2026; the largest reported position is Baupost Group's at $495.81M. Company insiders reported 1 open-market buy and 14 sales on SEC Form 4 in the 90 days to Nov 20, 2026. Its trailing P/E ratio is 17.9 and its net margin 2.5% (key statistics as of Nov 9, 2026).

$394.48
+1.11%
Last price
Source: Finnhub
Alpha Score
37
Weak

What is ELV's Alpha Score?

How it works →

Alpha Score of 37 reflects weak overall profile with weak momentum, weak value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.

Momentum
44
Weak
Value
41
Weak
Quality
38
Weak

Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.

Computed Nov 20, 2026

A rules-based research rating, not a recommendation to buy or sell.

Which members of Congress traded Elevance Health Inc. (ELV)?

Members
14
Disclosed trades
35
Purchases
21
Sales
14

Most recent: Alan Armstrong (purchase, Mar 27, 2026); records start Dec 20, 2022.

PoliticianTrade dateTypeAmount
Alan Armstrong
R-OK · Senate
2026-03-27purchase$1k – $15k
Markwayne Mullin
R-OK · Senate
2025-12-29purchase$15k – $50k
Lisa McClain
R-MI · House
2025-08-13sale$1k – $15k
Gil Cisneros
D-CA · House
2025-08-05purchase$1k – $15k
Lisa McClain
R-MI · House
2025-07-10purchase$1k – $15k
Lisa McClain
R-MI · House
2025-06-24purchase$1k – $15k
Gil Cisneros
D-CA · House
2025-05-30sale$1k – $15k
Rob Bresnahan
R-PA · House
2025-05-15sale$15k – $50k

From STOCK Act periodic transaction reports. House filings as of Nov 19, 2026.

Every member of Congress who traded ELV, with filing lags →

Which hedge funds own ELV?

From 13F filings
FundShares HeldPosition ValueChange vs prior Q
Baupost Group
Seth Klarman
1.28M$495.81Mn/a
Citadel
Ken Griffin
388K$150.99M-57%
Renaissance Technologies
Jim Simons (founder)
323K$125.44M+60%
Marshall Wace301K$116.99M+1332%
D.E. Shaw
David Shaw
151K$58.57M+7%
Hussman Investment Trust
John Hussman
4K$1.63MNEW
Millennium Management
Israel Englander
4K$1.53M-99%
Maverick Capital
Lee Ainslie
3K$1.35MNEW

13F holdings as of Sep 30, 2026

Explore all tracked funds →

Are Elevance Health Inc. insiders buying or selling?

SEC Form 4 filings
90 days to Nov 20, 2026
Buys
1
Sells
14
Net $
-$4.8M
Unique insiders
3
DateInsiderRoleTypeSharesValue
Nov 19, 26Peru Ramiro GDirectorBUY1.0K$384K
Nov 5, 26Lavu RatnakarEVP & Chief Digital Info OfrSELL1.3K$572K
Oct 22, 26Kaye MarkEVP & CFOSELL400$174K
Oct 22, 26Kaye MarkEVP & CFOSELL321$140K
Oct 22, 26Kaye MarkEVP & CFOSELL1.7K$724K
Oct 22, 26Kaye MarkEVP & CFOSELL560$245K
Oct 22, 26Kaye MarkEVP & CFOSELL240$105K
Oct 22, 26Kaye MarkEVP & CFOSELL1.2K$510K
Oct 22, 26Kaye MarkEVP & CFOSELL1.7K$758K
Oct 22, 26Kaye MarkEVP & CFOSELL2.3K$1.0M

SEC Form 4 filings as of Nov 20, 2026

See cluster-buy signals across all tickers →

What are ELV's key statistics?

P/E Ratio
17.89
EPS (TTM)
23.46
Dividend Yield
1.24%
Beta
0.59
Net Margin
2.55%
ROE
11.59%
Debt / Equity
0.73
52W High
$450.69
52W Low
$274.84

Key statistics as of Nov 9, 2026

How does ELV's valuation compare with the Healthcare sector?

MetricELVHealthcare medianCompanies in median
P/E ratio17.929.1147
Net margin2.55%3.59%223
Return on equity11.59%3.41%255
Dividend yield (payers)1.24%1.37%61

Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 22, 2026). P/E excludes loss-making companies.

AlphaScala analysis on ELV

Latest 1

ELV price chart

Powered by TradingView

What does Elevance Health Inc. do?

Elevance Health, Inc. is a leading health company that operates through key segments including Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment provides a comprehensive suite of commercial, Medicare, and Medicaid health plans, along with managed care options like preferred provider organizations, serving employers, individuals, families, and communities across multiple states via affiliates such as Anthem Blue Cross and Blue Shield and Wellpoint. CarelonRx delivers pharmacy services to both affiliated health plan members and external customers. Carelon Services integrates physical, behavioral, pharmacy, and social care to support whole health affordably through risk-based solutions, clinical expertise, and partnerships with health plans, government agencies, and providers. This holistic approach addresses physical, behavioral, and social needs, enhanced by digital tools and data insights for better outcomes, affordability, equity, and access. Founded in 1944 and headquartered in Indianapolis, Indiana, Elevance Health plays a pivotal role in the U.S. healthcare market by simplifying care delivery and advancing integrated health solutions for diverse populations.

CEO
Ms. Gail Koziara Boudreaux
Employees
96,129
Market Cap
$91.96B
Ask about ELVAI research agent